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The design of a randomised controlled trial
to evaluate the (cost-) effectiveness of the
posterolateral versus the direct anterior
approach for THA (POLADA – trial)
K. Rykov1* , I. H. F. Reininga2, B. A. S. Knobben1, M. S. Sietsma1 and B. L. E. F. ten Have1
Abstract
Background: Total hip arthroplasty (THA) is one of the most successful orthopaedic procedures. Because of the
increasing number of THAs, a growing demand for faster recovery and a greater emphasis on cost-effectiveness,
minimally invasive THAs have been introduced in the last decades. The direct anterior approach is a minimally
invasive, tissue-sparing approach in which intermuscular planes are used. Theoretically, this approach should result
in a faster recovery of physical functioning and higher health-related quality of life.
Methods/design: A randomised controlled trial will be performed. Patients will be randomly allocated to undergo
THA by means of the anterior or posterolateral approach. Both the intervention and control group will consist of
two subgroups: 1) patients with a good bone stock who will receive an uncemented femoral stem, and 2) patients
with a poor bone stock who will receive a cemented femoral stem. Patients between 18 and 90 years with primary
or secondary osteoarthritis will be included. Physical functioning and health-related quality of life will be assessed
by means of questionnaires. Additionally, performance based tests will be performed to objectively assess the
physical functioning. Cost-effectiveness will be assessed by obtaining data on medical costs in and outside the
hospital and other nonmedical costs. Measurements will take place preoperatively, two and six weeks, three months
and one year postoperatively.
Discussion: There is some evidence that the anterior approach results in reduced tissue damage and faster recovery in
the direct postoperative period, compared to the posterolateral approach. However, there is still a lack of well-designed
studies that have confirmed the better outcomes and cost-effectiveness of the anterior approach. Therefore, the
purpose of this study is to assess the physical functioning, health related quality of life and the cost-effectiveness
of the anterior approach, compared to the conventional posterolateral approach.
Trial registration: Netherlands Trial Registry, number 5343 (registration date April 12, 2015)
Background
Total hip arthroplasty (THA) is considered to be one of
the most successful orthopaedic interventions of the past
40 years, with 10-year survival rates exceeding 90% [1, 2].
The number of THAs has increased rapidly during the last
decade, because of ageing of Western societies and an in-
crease of the incidence of obesity. Additionally, THA is
nowadays not only performed in elderly patients, but also
in younger patients who are still members of the working
population. Driven by this growing demand for THA, to-
gether with a greater emphasis on cost-effectiveness in
health care and patients’ higher expectations of shorter
hospital stays and faster recovery, alternative surgical
procedures have been developed to improve the success
of THA. Minimally invasive total hip arthroplasty (MIS
THA) is one of these developments.
MIS THA aims at minimising damage to soft tissues
during surgery in order to enhance postoperative recovery
and, consequently, accelerate the return to normal daily
functioning [3]. Despite the increase in use of MIS THA,
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its risks and benefits are still an ongoing debate in the
orthopaedic community. There is a wide variety of MIS
THA procedures, which have shown variable results [4].
However, these variable results for MIS THA can for a
large part be contributed to the fact that some of these so-
called minimally invasive techniques, are actually not min-
imally invasive. There are patent differences between using
an alternate surgical approach intended to gain access to
the hip joint through less soft-tissue dissection and using
intermuscular planes (i.e. a tissue-sparing approach).
Hence, when one looks critically at the literature on MIS
THA, it appears that the term “minimally invasive” is
often used for a conventional THA technique performed
through a smaller skin incision, with at least the same
amount of tissue damage under the skin compared to the
conventional approach (i.e. mini-incision THA) [5].
The anterior approach for THA is a minimally inva-
sive, tissue-sparing technique. Conceptually, the anterior
approach should cause less tissue damage compared to
the conventional posterolateral approach, as intermuscular
planes are used without muscle dissection [6]. Moreover,
by (partially) dissecting several muscles around the hip,
the posterolateral approach is more prone for instability
postoperatively. Whereas with the anterior approach, the
musculature for pelvic stabilisation remains undisturbed
[7]. These muscles also play an important role in gait func-
tion. Hence, theoretically, the anterior approach should re-
sult in a faster recovery of physical functioning and, thus,
a higher health-related quality of life.
Little research has been conducted so far on the impli-
cations of MIS THA, and especially the direct anterior
approach (DAA) for THA, in elderly patients [8]. The
skeletal musculature of elderly patients possesses a
higher vulnerability and a reduced regenerative capacity
[9]. Additionally, elderly patients are characterized by a
higher incidence of postoperative fatty muscle atrophy,
which is associated with reduced muscular function [9].
More importantly, patients who underwent THA through
a conventional approach had a significantly higher grade
of muscle atrophy compared to older patients following
MIS THA. Muller et al. [9] concluded that especially
older patients seem to benefit from a minimally inva-
sive approach. Whether the previously mentioned re-
sults are also applicable for the anterior approach, is
still unknown.
The ability to ambulate independently is an important
hospital discharge criterion since a proper gait function
is crucial to perform several activities of daily living in-
dependently. Thus far, there are no studies that compare
the cost-effectiveness of the direct anterior approach.
Despite this, there is some evidence that accelerated
postoperative care can be cost saving [10]. In this respect
the anterior approach, because of its muscle sparing char-
acter and potentially faster recovery, might not only be a
clinically effective but also a cost-effective surgical tech-
nique for THA.
There is however a lack of well-designed studies, and
thus of objective evidence, on the effectiveness of the an-
terior approach. The scarce, but promising evidence that
is available is derived from retrospective case series or
small prospective trials [11–14]. Little is also known
about whether older patients even benefit more from the
anterior approach. Moreover, little information is present
about the cost-effectiveness of the anterior approach for
THA. Hence, the aim of this study is to conduct a rando-
mised controlled trial to determine the clinical and cost-
effectiveness of the direct anterior approach compared
with the conventional posterolateral approach for THA.
Methods/Design
Study design
A prospective randomised controlled trial will be exe-
cuted. Patients will be randomly allocated to undergo
THA by means of the direct anterior approach or the
posterolateral approach.
Study population and recruitment procedure
Patients will visit the outpatient clinic at the Department
of Orthopaedic Surgery at the Martini Hospital Groningen
where they will receive oral and written information about
the study. After screening according to the in- and exclu-
sion criteria (Table 1). Patients with a previous surgery of
the ipsilateral hip, complaints or a hip prosthesis of the
contralateral hip and symptomatic osteoarthritis of the
knee will be excluded, because these factors may influence
the gait analysis measurements and the questionnaires
when there are complaints or limitations in functioning
because of these factors. Pfirrmann et al. showed that pa-
tients with symptomatic complaints after THA have more
muscle atrophy [15]. Furthermore, evidence exists that
atrophic muscle might not regenerate postoperatively and
these factors are important in the assessment of physical
functioning [16]. Moreover, because patients of 90 years
Table 1 In- and exclusion criteria
Inclusion criteria Exclusion criteria
- Age between 18–90 years;
- Indication for THA is primary
or secondary symptomatic
osteoarthritis
- A history of previous surgery on the
ipsilateral hip;
- complaints of the contralateral hip;
- a hip prosthesis at the contralateral side;
- symptomatic osteoarthritis of the knee;
- peripheral neuropathy;
- (active) arthritis (e.g. rheumatic disease);
- a history of CVA;
- COPD GOLD III or IV
- NYHA class III or IV
- cognitive impairments.
- not able to fill in questionnaires in the
Dutch language
Abbreviations: THA Total Hip Arthroplasty, CVA Cerebrovascular Accident, COPD
Chronic Obstructive Pulmonary Disease, NYHA New York Heart Association
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and above have other comorbidities and are usually not
operated in our hospital, we will exclude these patients.
After the patients have had a consideration period of
two weeks, they will be included in the study. They will
then be randomised into either the control group (pos-
terolateral approach) or the intervention group (direct
anterior approach) by random allocation. Both the inter-
vention and control group will consist of two subgroups:
a subgroup with patients with a good bone stock that
will receive an uncemented femoral stem and a subgroup
of patients, with less good bone stock that will receive a
cemented femoral stem. The quality of the bone stock will
be determined by routine preoperative pelvic X-rays. Since
there are no studies that describe characteristics on which
the type of femoral component can be chosen on pelvic
X-rays, the quality of the bone stock will be determined by
the orthopaedic surgeons. The main determinant will be
the thickness of the femoral cortices. Because bone min-
eral density, and thus bone quality, decreases with age, this
will also be a determinant in the choice for the stem com-
ponent. Generally, patients with an age of 70 years or
more will receive a cemented femoral stem. The age of
70 years is chosen because of the lower revision rates and
cost-effectiveness with cemented femoral stems in this age
group [17]. However, this cut-off point remains arbitrary
since the life span of the older population can give mislead-
ing results on revision rates. Also, because of the longer life
span of the younger population, a revision of the femoral
because of aseptic loosening, will be less demanding with
an uncemented femoral stem.
Two random allocation sets (for the uncemented femoral
component and for the cemented femoral component) of
the type of THA approach will be generated by means of a
computer by an independent person (research coordin-
ator). These allocations are then sealed in consecutively
numbered opaque envelopes. Once the patient has given
consent to be included in the trial, the THA approach is
then randomly assigned by opening the next sealed enve-
lope, for either the uncemented or the cemented femoral
stem. After that, the envelope with the matching study
number is opened by an independent research nurse who
thus is blinded regarding the randomisation sequence. It is
not possible to blind the patient for the allocated surgical
technique, since the surgical incision site of the studied ap-
proaches is different (i.e. on the anterior or posterolateral
side of the hip joint).
It is expected that around 30% of the patients are in-
eligible or refuse to participate in the study. Hence,
approximately an inclusion period of 24 months will
be needed to include 260 patients.
Interventions
The orthopaedic surgeons who are participating in this
study (N = 3) are experienced in performing both the
posterolateral and the direct anterior approach. The learn-
ing curve for the anterior approach is said to be between
the 20 and 100 cases [18–21]. The three orthopaedic sur-
geons have reached a number beyond the 100 cases and
they will perform, or supervise, all THAs in the present
study. The anaesthetic, analgesic and postoperative
physical therapy protocols will be standardized. Discharge
criteria will also be the same in both study groups
(Additional file 1).
The type of femoral component that will be placed will
be based on the quality of the bone stock. Patients with
good firm bone stock of the proximal femur will receive
an uncemented stem (Taperloc™, Biomet Corporation,
The Netherlands), that will be hammered into the shaft
of the proximal femur. Patients with less firm bone stock
of the proximal femur will not receive an uncemented
stem, because of the risk of periprosthetic fractures during
stem insertion. They will get a cemented stem (Stanmore™,
Biomet Corporation, The Netherlands). In all groups, a
cemented acetabular component (Stanmore™, Biomet
Corporation, The Netherlands) will be placed.
Intervention group – direct anterior approach
Advantage of the anterior approach is the possibility of
using intermuscular planes, avoiding muscle damage by
cutting or detaching muscles. The patient is placed in a
supine decubitus position. The skin incision is made
over, and in the direction of the lateral part of the femoral
head and neck. After division of skin and subcutis, the
interval between the tensor fasciae latae muscle and the sar-
torius muscle is identified and the overlying fascia is
opened. In this part of the operation care must be taken to
avoid damaging the lateral cutaneous nerve, supplying the
sensation of the skin on the lateral part of the thigh. The
intermuscular plane between the tensor fasciae latae and
sartorius muscle is developed further down to the hip cap-
sule. Subsequently the hip capsule is opened, allowing ac-
cess to the hip joint. Preparation of the hip for implantation
of a hip prosthesis can take place now, by in situ perform-
ance of the femoral neck osteotomy, removal of the femoral
head and reaming of the acetabulum. Next, bone cement
(Palacos®, Heraeus Medical, The Netherlands) is pressurized
into the acetabular cavity, followed by insertion of the ace-
tabular cup. After reaming of the femur, the femoral com-
ponent can be placed with or without bone cement,
followed by placement of a head on the femoral compo-
nent, repositioning of the joint and closure in layers. In case
of a cemented femoral component, bone cement is pressur-
ized into the femoral cavity before the femoral component
of the hip prosthesis is placed.
Control group – posterolateral approach
The patient is placed in a lateral decubitus position. The
skin incision is made over the greater trochanter to
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cranial, with a slight curve to posterior. After transection
of the subcutis, the fascia latae and the gluteus maximus
muscles are split. Next, the short external rotators,
namely the piriformis, the inferior and superior gemellus
and the obturator internus muscles, are cut at the level
of their insertion at the greater trochanter, so this ap-
proach is not muscle-sparing. In this phase of the pro-
cedure, caution is advised with the sciatic nerve, the
main nerve for the lower leg. After retraction of the
short external rotators backwards, the hip capsule be-
comes visible and can be incised, allowing access to the
hip joint. Subsequently, the hip joint is then dislocated
and the osteotomy of the femoral neck is performed,
followed by the removing of the femoral head. The rest
of the operation will essentially take place in the same
manner as the anterior approach.
Measurements
Measurements will be performed by an independent
investigator. Standard measurement will take place
preoperatively, and six weeks, three months and one
year postoperatively. As it is hypothesised that the anterior
approach is superior to the posterolateral approach in
terms of a faster recovery, mainly in the early recovery
period (shorter hospital stay, faster return to normal ADL
functioning), extra measurements of physical function, gait
analysis and economic evaluation will take place two
weeks postoperatively. The questionnaire will be sent to
the patients a few days prior to the visit or – when patient
do not have an email – will be filled in during the clinical
outpatient visit. The filling in of the questionnaire will
approximately take 30 to 45 min of patients’ time. A
CONSORT flow chart is provided in Fig. 1. Demographic
Fig. 1 CONSORT flow chart
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data, preoperative diagnosis, height, weight and Body
Mass Index (BMI), ASA classification and the Kellgren
and Lawrence (KL) score will be recorded preoperatively.
Perioperative measurements
Surgical time, rate of complications, position of the fem-
oral and acetabular components and length of hospital
stay will be recorded. Position of the femoral and acetabu-
lar components will be measured on an anterioposterior
(AP) pelvic X-ray. Inclination of the acetabular component
will be measured by defining the angle between the tear
drop line and the cup. The version of the cup will be mea-
sured by using the method described by Lewinnek et al.
[22]. Both the cup version and inclination have been
proven to have a high inter- and intraobserver reliability
and have been proven to be a reliable and valid method
when compared to the gold standard. [23–25] Varus and
valgus alignment of the stem will be measured by taking
the angle between the femoral shaft and the prosthetic
component [26]. These measurements will be performed
by KR and an independent orthopaedic surgeon. Measure-
ments will be performed on standard outpatient visits six
weeks and one year postoperatively. Additionally, amount
of blood loss will be calculated from the drop in postoper-
ative blood hematocrit levels, according to the formula of
Nadler et al. [27].
Physical functioning and health-related quality of life
Main study parameter is the Patient Acceptable Symptom
State (PASS), which is an approach to measure patient’s
responses to treatment. The concept of PASS is based on
wellbeing or satisfaction with the actual symptoms and is
defined as the value on a patient-reported outcome meas-
ure (PROM) beyond which patients consider themselves
well [28, 29]. The use of PASS is therefore a simple way to
determine whether a patient has achieved therapeutic suc-
cess. PROMs estimate the effectiveness of healthcare de-
livered to patients as perceived by the patients themselves.
The PASS score is determined by assessing the score on a
PROM of patients who are satisfied with their actual phys-
ical state and symptoms. Based on patients’ satisfaction
with symptoms, the optimal cut-off value of the used
PROM can be determined [30–32]. In this study, PASS
scores will be derived from scores on the Hip disabilities
and Osteoarthritis Outcome Score (HOOS) [33], and they
will be determined for the measurements made at two and
six weeks, three months and one year postoperatively. The
HOOS consists of 5 subscales; pain, other symptoms,
function in daily living, function in sport and recreation,
and hip-related quality of life. The last week is taken into
consideration when answering the questions. The Dutch
version of the HOOS is considered valid and reliable [33].
Additionally, the patients’ opinion about “actual satisfac-
tion with their symptoms regarding their hip problem” will
be asked with one question. This question will be “if you
spend the rest of your life with the hip symptoms you have
now, how would you feel?” A Likert version of this ques-
tion will be used with four response levels: very satisfied,
somewhat satisfied, somewhat dissatisfied and very dissat-
isfied [29, 30, 32]. The scores on this question are then
used to calculate PASS. The PASS scores at the previous
mentioned time points will each be compared with the
preoperative state and then compared between the two
approaches [30].
The EuroQol questionnaire (EQ-5D) will also be ad-
ministered. The health outcomes of the two approaches
for THA will be assessed in terms of quality adjusted life
years (QALYs). This reflects any differences in health-
related quality of life based on the patients’ responses to
the EQ-5D questionnaire preoperatively and at up to
three points after hospital discharge (six weeks, three
months and one year postoperatively). The EQ-5D is a
generic questionnaire and consists of 5 questions regard-
ing health-related quality of life [34]. The EQ-5D will also
be used as a preference-based measure of health status for
the cost-effectiveness analysis [35].
Next to the previous mentioned questionnaires the
global rating of change will be assessed [36]. A global
rating of change is a single item with which the overall
(global) perceived improvement in physical functioning
following THA can be assessed. This question is scored on
a 7-point likert scale (1 = completely recovered; 2 =much
improved; 3 = slightly improved; 4 = not changed; 5 =
slightly deteriorated; 6 = much deteriorated; 7 = worse
than ever), and asks for the change in physical func-
tioning following THA.
The International Consultation of Incontinence
Questionnaire-Short Form (ICIQ-SF) will be adminis-
tered to evaluate whether THA has influence on urine
incontinence [37]. The ICIQ-SF is a subjective ques-
tionnaire and is a recommended method to assess the
grade of urine incontinence [38]. It consists of four
questions on the frequency and volume of urine in-
continence and its influence on daily life [37]. With
the posterolateral approach the short external rotators
of the hip are detached of the greater trochanter. Since
the obturator internus muscle is connected to the pel-
vic floor musculature detachment of this muscle may
have a negative effect to urine continence [39, 40],
whereas with the anterior approach the pelvic floor re-
mains undisturbed.
Physical activity behaviour will be assessed by means
of the International Physical Activity Questionnaire
(IPAQ) [41]. IPAQ consists of 27 items which are pre-
structured into five subcategories: 1) job-related physical
activity; 2) transportation-related physical activity; 3)
housework, house maintenance, and caring for family; 4)
recreation, sports and leisure-time physical activity; and
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5) time spent sitting. The IPAQ records the activity of
four intensity levels: 1) vigorous-intensity activity such
as aerobics, 2) moderate-intensity activity such as leisure
cycling, 3) walking, and 4) sitting. The Dutch version of
the IPAQ is considered valid and reliable [42].
Gait function
As walking is by far the most important aspect of func-
tional status, physical functioning will be objectively
measured by means of gait analysis. The Timed Up and
Go (TUG) test, the 4x10m self-paced walk test (SPWT),
the stair-climb test (SCT) and the 30-s chair stand test
(30s-CST) will be used to assess the physical perform-
ance. The TUG test measures the time needed for the
patient to stand up from a chair, walk 3 m, turn, walk
back to the chair and sit down. This test has been used
to assess the functional activity [43]. For the SPWT the
patient has to walk 10 m in a paced, but comfortable
way and repeat this four times, for a total of distance
40 m [44]. The time the patient needs to cover this dis-
tance is measured, and the mean speed is calculated. For
the SCT the patient is asked to ascend and then descend
a stairs with 10 steps [45]. Finally, for the 30s-CST,
the patient is asked to stand up and sit down in a chair
as many time as possible. All four tests have been sug-
gested as reliable and valid measures to compare out-
comes after THA, and they are the recommended
performance-based tests to assess the physical functioning
before and after THA [45, 46].
Participation
To assess social participation, the subscale Participation
of the World Health Organisation Disability Assessment
Schedule II (WHODAS II) questionnaire [47, 48] will be
assessed six weeks, three months and one year postopera-
tively. This subscale of the WHODAS II consists of 10
items asking about problems with participation in society.
All questions are scored on a 5-item Likert scale ranging
from no problem to extreme problems/cannot do. The
last 30 days are taken into consideration when answering
the questions. The Dutch version of the WHODAS II is
considered valid and reliable [48].
Economic evaluation
An economic evaluation will be conducted to gain insight
into cost-effectiveness of the anterior approach compared
to the posterolateral approach for THA. After completion
of the data collection, the health status, as determined by
means of the EQ-5D, will be related to costs in additional
economic analyses. These analyses will provide informa-
tion on the probable cost-effectiveness of the anterior ap-
proach compared to the posterolateral approach for THA
in the Dutch healthcare system.
The evaluation will be performed from a societal perspec-
tive; costs within and outside the healthcare sector will be
included. Costs will be registered prospectively, i.e. within
the framework of the current study, for all the included
patients. A standardised questionnaire on medical costs
after THA will be administered at two and six weeks,
three months and one year postoperatively. The question-
naire is set up by the Medical Technology Assessment
(MTA) and is used in the cost-effectiveness analyses. It
contains 11 questions on indirect medical and non-medical
issues regarding the THA outside of the hospital. Medical
questions include hospital readmissions, visits to the
hospital and/or other (paramedical) healthcare workers.
Non-medical questions concern patients’ living and
working situation.
The direct medical costs, such as the use of the operative
theatre, hospital admission and additional interventions
(e.g. blood transfusions) will be compared between the two
approaches. Most salient cost advantages of the anterior ap-
proach are expected in the area of hospitalization costs. Of
the various nonmedical costs, informal care costs are as-
sumed to be substantial in the targeted population and will
be registered in detail (e.g. visits to the general practitioner,
physical therapy). In order to facilitate comparisons with
other economic evaluations, unit prices (i.e. the price of
one unit of each included cost type) are based on Dutch
standard prices [49]. True costs of used resources will be
estimated when standard prices are not available.
Sample size calculation
Escobar et al. [30] showed that 70% of patients achieved
an acceptable symptom state (PASS) at three months
following THA, which means they have a positive PASS.
The hypothesis is that the anterior approach results in a
larger proportion of patients with a positive PASS at
three months following THA. A difference of 20% in the
proportion of patients with a positive PASS between the
anterior approach and the posterolateral approach is
considered clinically significant, as is described is de-
scribed in the OMERACT-OARSI criteria [50]. Hence,
based on the results of Escobar et al., a sample size of 60
patients in each study subgroup is needed to detect this
difference of 20%, with a power of 80% and an alpha of
5%. Hence, each arm of the RCT needs to contain 120
patients. Based on previous experience, it is expected
that approximately 10% will be lost in the follow-up.
Hence, the total sample size will be set at 260 patients.
Statistical analysis
To analyse the data SPSS (Statistical Package for the So-
cial Sciences, Chicago, Illinois) will be used. A p-value
of < .05 will be considered to indicate statistical significance.
Descriptive statistics (means and standard deviations)
will be used to describe the subject characteristics and
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the results of the groups. The PASS score is determined
by assessing the score on the HOOS of patients who are
satisfied with their actual physical state and symptoms.
PASS scores will be determined for the measurements
made at six weeks, three months and one year postopera-
tively. The satisfaction question, which is asked on a four-
response Likert scale, will be dichotomized into “satisfied”
(i.e. the patients who are “very satisfied” or “somewhat sat-
isfied”) and “unsatisfied” (i.e. the patients who are “some-
what dissatisfied” or “very dissatisfied”) [30, 32]. This
dichotomized variable will then be used as anchor to cal-
culate cut-off values on the HOOS to determine the PASS
score. Next, a ROC analysis will be conducted, using the
satisified/dissatisfied variable as anchor. As optimal cut-off
value will be the one that maximizes the sum of sensitivity
and specificity [30].
After that, all patients will be categorized as responders
(i.e. a score on the HOOS beyond the PASS score) and
non-responders. Chi-square tests will be used to deter-
mine potential differences in the proportion of responders
between the study and control group at the above-stated
time-points. Additionally, odds ratios with corresponding
95% confidence interval (CI) will be calculated. This ratio
represents the odds of being a “responder” for the study
group, compared to the control group. An odds ratio lar-
ger than 1 favours the study group and the point estimate
of the odds ratio is considered to be statistically significant
if the 95% CI does not include the value of 1.
Changes in physical activity, participation and gait
function will be analyzed with Generalized Estimating
Equations (GEE) analyses [51]. Analysis of Variance
(ANOVA) will be used to assess differences in urine
incontinence (ICIQ-SF), radiographic measurements,
surgical time, blood loss and length of hospital stay
between the study and control group. Differences in
complication rates will be assessed by means of a Chi-
square test.
For both the study and control group the mean costs,
mean effects (measured with HOOS) and mean QALY
(based on the utility scores of the EQ-5D) will be calcu-
lated. Next, mean costs, mean effects and mean QALYs
are used to calculate the incremental costeffectiveness
ratio (ICER) [52] by dividing the difference in costs by
the difference in effects/QALYs between the study and
control group. Uncertainty surrounding the calculated
ICER will be examined by the bootstrap method. Incre-
mental cost-effectiveness ratios will be calculated for
each of the bootstrap iterations (5000 in the present
study), which then will be combined to form a mean
ICER with corresponding 95% CI.
Discussion
THA can be performed through several different ap-
proaches to the hip joint. These approaches include the
anterior, anterolateral, direct lateral, transtrochanteric,
posterolateral, and posterior approach. The posterolateral
approach is the most commonly used approach [53].
In the last decade minimal invasive surgery techniques
for THA have been introduced with the goal of reducing
tissue trauma, shorten the length of hospital stay and
enhance faster recovery. In the literature minimally inva-
sive techniques are described by an incision that is less
than 10 cm in length. However, some of these tech-
niques still cause tissue damage because of soft-tissue
dissection [5]. The direct anterior approach on the other
hand is a tissue-sparing approach in which intermuscu-
lar planes are used to get to the hip joint. Theoretically
the anterior approach should result in less tissue damage
when compared to the posterolateral approach in which
several of the muscles are being dissected. Additionally,
because the pelvic musculature remains undisturbed
with the anterior approach, it should result in a faster
postoperative recovery.
Opponents of the anterior approach claim that it is a
more technically demanding approach, which results in
a longer operative time, more blood loss and an increase
in complications during surgery [54–56]. Moreover, it is
said that the anterior approach has a long learning
curve, ranging from 20 up to 100 patients [18–21].
However, with more experience a decrease in blood loss,
operative time and number of complications is to be ex-
pected [19–21]. In the current study all three ortho-
paedic surgeons are far beyond their learning curve.
The importance of the pelvic musculature in THA pa-
tients has been shown in a study by Pfirrmann et al.
[15]. In their MRI study they found that patients with
persistent symptoms of the operated joint had more de-
fects of the gluteal musculature. Bremer et al. found that
the direct anterior approach resulted in less soft-tissue
damage to the abductors on MR images, compared to
the transgluteal approach [57]. Moreover, Mayr et al.
found that the gait function improved in the direct an-
terior group in the direct postoperative period [12].
Lugade et al. found comparable results [58]. These find-
ings suggest that the direct anterior approach results in
a faster recovery. However, these promising results are
contradicted in other studies [59, 60].
There is still an ongoing debate within the orthopaedic
community about the direct anterior approach for THA.
This is partly due to the lack of well-designed prospect-
ive, randomized trials comparing the direct anterior with
the most commonly used posterolateral approach. More-
over, there is a lack of literature about the cost-effectiveness
of this tissue-sparing approach for THA. Therefore, the
aim of this article is to compare the (cost-) effectiveness of
the direct anterior approach with the posterolateral ap-
proach, with the hypothesis that the direct anterior ap-
proach will lead to faster recovery and a decrease in costs.
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